BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32883160)

  • 1. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome.
    de Jesús GR; Benson AE; Chighizola CB; Sciascia S; Branch DW
    Lupus; 2020 Oct; 29(12):1601-1615. PubMed ID: 32883160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome.
    de Jesus GR; Agmon-Levin N; Andrade CA; Andreoli L; Chighizola CB; Porter TF; Salmon J; Silver RM; Tincani A; Branch DW
    Autoimmun Rev; 2014 Aug; 13(8):795-813. PubMed ID: 24650941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Legault K; Erkan D
    Lupus; 2020 Oct; 29(12):1594-1600. PubMed ID: 32819183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
    Cohen H; Cuadrado MJ; Erkan D; Duarte-Garcia A; Isenberg DA; Knight JS; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Williams DJ; Willis R; Woller SC; Andrade D
    Lupus; 2020 Oct; 29(12):1571-1593. PubMed ID: 33100166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.
    Bertolaccini ML; Amengual O; Andreoli L; Atsumi T; Chighizola CB; Forastiero R; de Groot P; Lakos G; Lambert M; Meroni P; Ortel TL; Petri M; Rahman A; Roubey R; Sciascia S; Snyder M; Tebo AE; Tincani A; Willis R
    Autoimmun Rev; 2014 Sep; 13(9):917-30. PubMed ID: 24824074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of the Obstetric APS Task Force: 13th International Congress on Antiphospholipid Antibodies, 13th April 2010.
    Branch W;
    Lupus; 2011 Feb; 20(2):158-64. PubMed ID: 21303832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
    Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD
    Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.
    Ruiz-Irastorza G; Cuadrado MJ; Ruiz-Arruza I; Brey R; Crowther M; Derksen R; Erkan D; Krilis S; Machin S; Pengo V; Pierangeli S; Tektonidou M; Khamashta M
    Lupus; 2011 Feb; 20(2):206-18. PubMed ID: 21303837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
    Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
    Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
    Cervera R; Rodríguez-Pintó I; Colafrancesco S; Conti F; Valesini G; Rosário C; Agmon-Levin N; Shoenfeld Y; Ferrão C; Faria R; Vasconcelos C; Signorelli F; Espinosa G
    Autoimmun Rev; 2014 Jul; 13(7):699-707. PubMed ID: 24657970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010.
    Pierangeli SS; de Groot PG; Dlott J; Favaloro E; Harris EN; Lakos G; Ortel T; Meroni PL; Otomo K; Pengo V; Tincani A; Wong R; Roubey R
    Lupus; 2011 Feb; 20(2):182-90. PubMed ID: 21303835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
    Tenti S; Cheleschi S; Guidelli GM; Galeazzi M; Fioravanti A
    Autoimmun Rev; 2016 Mar; 15(3):226-35. PubMed ID: 26656906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.
    Bertolaccini ML; Amengual O; Atsumi T; Binder WL; de Laat B; Forastiero R; Kutteh WH; Lambert M; Matsubayashi H; Murthy V; Petri M; Rand JH; Sanmarco M; Tebo AE; Pierangeli SS
    Lupus; 2011 Feb; 20(2):191-205. PubMed ID: 21303836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.
    Barbhaiya M; Andrade D; Erkan D;
    Curr Rheumatol Rep; 2016 Oct; 18(10):64. PubMed ID: 27646150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome.
    Cervera R
    Thromb Res; 2017 Mar; 151 Suppl 1():S43-S47. PubMed ID: 28262233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
    Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
    Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insights in obstetric antiphospholipid syndrome.
    Schreiber K; Radin M; Sciascia S
    Curr Opin Obstet Gynecol; 2017 Dec; 29(6):397-403. PubMed ID: 28915160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.